Cognitive behavior therapy boosts outcomes in depressed diabetes patients

11/1/2013 | DailyRx.com

Data on patients with uncontrolled type 2 diabetes and depression revealed that those who underwent cognitive behavioral therapy for adherence and depression attained better HbA1C levels and exhibited greater adherence to oral medication and self-monitoring of blood glucose at four months compared with those in the Enhanced Treatment as Usual arm. The findings were published in Diabetes Care.

View Full Article in:

DailyRx.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ